iBio, Inc. (IBIO) has a consensus analyst rating of Buy, based on 4 analysts covering the stock. Of those, 3 recommend buying, 1 recommend holding, and 0 recommend selling.
The analyst consensus price target for IBIO is $2.00, representing a -8.7% downside from the current price of $2.19. Price targets range from a low of $2.00 to a high of $2.00.
